Question 1

What is this medicine for, and how does it work?

Accepted Answer

This is a monoclonal antibody. It blocks a protein called VEGF to prevent new blood vessel formation. It is used to treat age-related macular degeneration.

Question 2

When and how should this medicine be taken?

Accepted Answer

• For intravitreal injection only • Must be administered by qualified healthcare provider • Single-use only

Question 3

When should this medicine not be used?

Accepted Answer

• Monitor for retinal problems • Check blood pressure regularly • Use caution in diabetes • Watch for eye infections • Regular eye examinations needed

Question 4

What precautions should be taken before using this medicine?

Accepted Answer

• Monitor for retinal problems • Check blood pressure regularly • Use caution in diabetes • Watch for eye infections • Regular eye examinations needed • Check for cardiovascular risk

Question 5

Is it safe to use this medicine during pregnancy?

Accepted Answer

• Limited data available; • Use only if clearly needed; • Consult doctor before use

Question 6

Can this medicine be used while breastfeeding?

Accepted Answer

• Monitor for retinal problems • Check blood pressure regularly • Use caution in diabetes • Watch for eye infections • Regular eye examinations needed • Check for cardiovascular risk

Question 7

What should be done if a dose is missed?

Accepted Answer

• If you miss a dose, take it as soon as you remember. • However, if it's almost time for your next dose, skip the missed dose. • Never take two doses together. • If taken with meals: Take the dose with your next meal. • For thrice-daily dosing: If more than 3 hours until your next dose, take the missed dose. • Take your next dose at the regular time. • If you're unsure, contact your doctor or pharmacist.

Question 8

What should be done in case of an overdose?

Accepted Answer

• Symptoms: Eye inflammation, increased IOP. • Treatment: IOP monitoring, inflammation control.

Question 9

What should be done if side effects are experienced?

Accepted Answer

• Common side effects: Eye bleeding, pain, floaters, increased pressure, irritation, inflammation• What to do:- Regular eye checks- Report vision changes- Monitor eye pressure- Keep eyes clean- Complete treatment course; Stop taking the medication and seek medical advice if any severe side effect or unusual symptoms occur.

Question 10

What medical indications are treated with Ranibizumab?

Accepted Answer

Ranibizumab (Drugs For Age-Related Macular Degeneration (AMD)) is a pharmaceutical active substance. It is indicated for the treatment of Central Retinal Vein Occlusion, Diabetic Macular Edema, Wet ARMD.

Question 11

What is the recommended dosage for Ranibizumab?

Accepted Answer

Standard adult dosage: Intravitreal Injection – 0.5 mg (0.05 mL of 10 mg/mL) (monthly). Pediatric dosage: Intravitreal injection – 0.2 mg (Single injection per eye). Always consult a registered physician for individualized dosage adjustments based on clinical assessment.

Question 12

Is Ranibizumab safe during pregnancy and breastfeeding?

Accepted Answer

Ranibizumab is classified under Pregnancy Category "Not Assigned". Always consult your healthcare provider or OB/GYN before taking this medication during pregnancy or lactation.

Question 13

What are the common side effects of Ranibizumab?

Accepted Answer

**More than 10%**; Conjunctival hemorrhage (43-77%);Eye pain (17-37%);Vitreous floaters (3-32%);Incr IOP (8-24%);Vitreous detachment (7-22%);Eye irritation (4-19%);Intraocular inflammation (5-18%);Headache (2-15%);Upper

Clinical Information	Administration Information
Indication: Neovascular (wet) age-related macular degeneration Age: Adult	Dose: Intravitreal Injection – 0.5 mg (0.05 mL of 10 mg/mL) Frequency: monthly Note: Continue treatment until visual acuity is stable for 3 consecutive months. Doses are given at intervals of at least 1 month.
Indication: Macular oedema secondary to retinal vein occlusion Age: Adult	Dose: Intravitreal Injection – 0.5 mg Frequency: monthly Duration: 6 months Note: Doses are given at intervals of at least 1 month.

Drug Name	Risk Factors
Belimumab	May enhance the adverse/toxic effect
Verteporfin photodynamic therapy (PDT)	Serious intraocular inflammation may occur when used adjunctively

Disease Name	Risk Factors
Active ocular infection	Can worsen infection
Active severe intraocular inflammation	Risk of complications

Medicine Overview

Indication

What is this medicine for, and how does it work?

When and how should this medicine be taken?

When should this medicine not be used?

What precautions should be taken before using this medicine?

Is it safe to use this medicine during pregnancy?

Can this medicine be used while breastfeeding?

What should be done if a dose is missed?

What should be done in case of an overdose?

What should be done if side effects are experienced?

Adult Dose

Child Dose

Drug Interaction

Disease Interaction

Pregnancy

Data Sources